Diabetech - Diabetes Tech, Research, News

Justin Eastzer

We cover diabetes technology, news, research, and management tips through expert interviews and people with diabetes who use the tech. We cover all the insulin pump and continuous glucose monitor (CGM) updates, patient stories and news from every diabetes conference.

  1. 11/24/2025

    Is Your Pump Secure? A Cybersecurity Expert Breaks It Down

    I sit down with Josiah Dykstra—a cybersecurity expert who spent nearly two decades at the NSA and has lived with type 1 diabetes for over 30 years—to explore what diabetes management looks like inside some of the most locked-down buildings in the world. We talk about what happens when your phone, smartwatch, and even certain medical devices are banned; why a standalone Dexcom receiver became essential for his T1D care; and how government security teams decide which pumps, CGMs, pacemakers, and hearing aids are safe enough to enter classified spaces. Josiah opens up about his long-standing fears around pump hacking, why early insulin pump vulnerabilities shook the cybersecurity world, how risk decisions are made at the highest levels, and what finally convinced him to consider automated insulin delivery. We also dig into FDA regulation, the evolving state of medical device cybersecurity, and what all of this means for the future of diabetes tech.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    45 min
  2. 11/17/2025

    The Future of Insulin Pumps: Inside the Next-Gen Pump Wars

    I sit down with endocrinologist and diabetes tech expert Dr. David Ahn to unpack the future of tubeless insulin pumps and automated insulin delivery for people with type 1 diabetes. We break down how companies like Omnipod, Tandem (with its tubeless Mobi and 7-day infusion set), Beta Bionics with its reusable mint patch pump, and Medtronic’s upcoming MiniMed Fit are racing to own the next generation of patch pumps. We talk about what Omnipod needs to do with its next-gen system to stay competitive, why 7-day wear and reusable parts matter, and how algorithms—from Loop to iLet—are evolving toward more hands-off, closed-loop insulin delivery. We also dig into big questions around dual-hormone systems using glucagon, how far current CGM technology can really take us, and whether fully closed-loop insulin pump systems without carb counting are actually realistic.   Join the Diabetech Newsletter   Learn about Omnipod 5 (today's sponsor)*   T1D Exchange Registry Sign up  (US residents only)   Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads   DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care.    *10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.

    1h 4m
4.7
out of 5
47 Ratings

About

We cover diabetes technology, news, research, and management tips through expert interviews and people with diabetes who use the tech. We cover all the insulin pump and continuous glucose monitor (CGM) updates, patient stories and news from every diabetes conference.

You Might Also Like